Theratechnologies (TH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 05-2010 | 02-2010 | 11-2009 | 08-2009 | 05-2009 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 167 | 140 | 176 | 142 | 135 |
| Accounts receivable | 102 | 85 | 1,033 | -142 | 26 |
| Other Working Capital | -660 | -3,630 | 1,659 | -1,183 | -2,936 |
| Other Operating Activity | -4,413 | -3,898 | -5,604 | 5,716 | -4,737 |
| Operating Cash Flow | $-4,804 | $-7,303 | $-2,737 | $4,533 | $-7,512 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -152 | -166 | -120 | -49 | -122 |
| Purchase Of Investment | 0 | 0 | -9,599 | 86 | 0 |
| Sale Of Investment | 5,041 | 9,158 | 1,866 | 3,575 | 4,823 |
| Investing Cash Flow | $4,889 | $8,992 | $-7,854 | $3,612 | $4,701 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -22 | 36 | 404 | -43 | 6 |
| Other Financing Activity | 86 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $64 | $36 | $404 | $-43 | $6 |
| Beginning Cash Position | 3,170 | 1,445 | 11,618 | 3,517 | 6,322 |
| End Cash Position | 3,314 | 3,170 | 1,436 | 11,618 | 3,517 |
| Net Cash Flow | $150 | $1,725 | $-10,187 | $8,102 | $-2,805 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,804 | -7,303 | -2,737 | 4,533 | -7,512 |
| Capital Expenditure | -152 | -166 | -120 | -49 | -122 |
| Free Cash Flow | -4,956 | -7,469 | -2,857 | 4,483 | -7,634 |